A New Murine Model of Osteoblastic/Osteolytic Lesions from Human Androgen-Resistant Prostate Cancer-Reference-Cited by-同舟云学术

A New Murine Model of Osteoblastic/Osteolytic Lesions from Human Androgen-Resistant Prostate Cancer

Published:2013-09-19 Issue:9 Volume:8 Page:e75092
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Fradet Anaïs,Sorel Hélène,Depalle Baptiste,Serre Claire Marie,Farlay Delphine,Turtoi Andrei,Bellahcene Akeila,Follet Hélène,Castronovo Vincent,Clézardin Philippe,Bonnelye Edith

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Bone and prostate cancer cell interactions in metastatic prostate cancer;I Vela;BJU Int,2007

2. Histopathological assessment of prostate cancer bone osteoblastic metastases;MP Roudier;J Urol,2008

3. Prostate cancer bone metastases promote both osteolytic and osteoblastic activity;ET Keller;J Cell Biochem,2004

4. Cancer to bone: a fatal attraction;KN Weilbaecher;Nat Rev Cancer,2011

5. Biology of bone metastases;RL Theriault;Cancer Control,2012

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The TREK-1 potassium channel is involved in both the analgesic and anti-proliferative effects of riluzole in bone cancer pain;Biomedicine & Pharmacotherapy;2024-07

2. Dickkopf-1 (DKK1) drives growth and metastases in castration-resistant prostate cancer;Cancer Gene Therapy;2024-05-13

3. Fascin-1 expression is associated with neuroendocrine prostate cancer and directly suppressed by androgen receptor;British Journal of Cancer;2023-10-24

4. NALCN‐mediated sodium influx confers metastatic prostate cancer cell invasiveness;The EMBO Journal;2023-06-06

5. Nano-Hydroxyapatite/PLGA Mixed Scaffolds as a Tool for Drug Development and to Study Metastatic Prostate Cancer in the Bone;Pharmaceutics;2023-01-11